A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer
- Joel Picus
- , Susan Halabi
- , W. Kevin Kelly
- , Nicholas J. Vogelzang
- , Young E. Whang
- , Ellen B. Kaplan
- , Walter M. Stadler
- , Eric J. Small
Research output: Contribution to journal › Article › peer-review
71
Link opens in a new tab
Scopus
citations